Advantage Alpha Capital Partners’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,737
Closed -$386K 163
2024
Q3
$386K Buy
+10,737
New +$386K 0.09% 150